Interações medicamentosas
Anagrelide + Caplacizumab
Gravidade: Grave
Anagrelide and Caplacizumab: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Caplacizumab blocks von Willebrand factor-mediated platelet adhesion and anagrelide reduces platelet aggregation and count, so together they may increase the risk of serious bleeding. Bleeding is the main adverse effect of caplacizumab.
O que esta interação significa em palavras simples
Anagrelide and Caplacizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Anagrelide belongs to Cardiovascular; Caplacizumab belongs to Cardiovascular.
Por que acontece
Additive impairment of primary hemostasis through different antiplatelet pathways.
O que fazer
Avoid combined use where possible; if anagrelide must be continued, monitor closely for bleeding and check platelet count and hemoglobin. Hold therapy as advised in caplacizumab labeling if significant bleeding occurs.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Anagrelide e Caplacizumab, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outras interações de Anagrelide
- Anagrelide + Panobinostat Contraindicada
- Anagrelide + Pimozide Contraindicada
- Anagrelide + Thioridazine Contraindicada
- Anagrelide + Vandetanib Contraindicada
- Abrocitinib + Anagrelide Grave
- Alfuzosin + Anagrelide Grave
Outras interações de Caplacizumab
Perguntas frequentes
Can I take Anagrelide with Caplacizumab?
MediHelp rates the interaction as major. Anagrelide and Caplacizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Caplacizumab blocks von Willebrand factor-mediated platelet adhesion and anagrelide reduces platelet aggregation and count, so together they may increase the risk of serious bleeding. Bleeding is the main adverse effect of caplacizumab.
How serious is the interaction between Anagrelide and Caplacizumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combined use where possible; if anagrelide must be continued, monitor closely for bleeding and check platelet count and hemoglobin. Hold therapy as advised in caplacizumab labeling if significant bleeding occurs.
What other medicines interact with Anagrelide?
MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
